Search
Lonicera caprifolium flower
go.drugbank.com/drugs/DB14280ApprovedLonicera caprifolium flower is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Larix sibirica wood
go.drugbank.com/drugs/DB14289ApprovedWithdrawnLarix sibirica wood is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Apricot kernel oil
go.drugbank.com/drugs/DB14324ApprovedApricot kernel oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Azadirachta indica leaf
go.drugbank.com/drugs/DB14352ApprovedAzadirachta indica leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
ZYCOV-D
go.drugbank.com/drugs/DB15892ExperimentalAs of August, 2020 the candidate is in Phase II clinical trials[A219758]. … The ZYCOV-D vaccine candidate was developed by Cadila Healthcare Ltd. based in India[A219758].
Desonide
go.drugbank.com/drugs/DB01260ApprovedInvestigationalA nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses.
Mixtures: APOLAR N, DESOLEX-NNorclozapine
go.drugbank.com/drugs/DB05766InvestigationalIt combines an atypical antipsychotic efficacy profile with the added potential benefit of enhanced cognition, thereby addressing one of the major challenges in treating schizophrenia today. … ACP-104, or N-desmethylclozapine, is the major metabolite of clozapine, and is being developed by ACADIA as a novel, stand-alone therapy for schizophrenia.
Synonyms: N-DesmethylclozapineTelratolimod
go.drugbank.com/drugs/DB19590InvestigationalTelratolimod is under investigation in clinical trial NCT06680479 (Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy … The usage of the INN stem '-tolimod' in the name indicates that Telratolimod is a toll-like receptor (TLR) agonist.
Rezivertinib
go.drugbank.com/drugs/DB21471InvestigationalRezivertinib is under investigation in clinical trial NCT06955325 (Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations). … The usage of the INN stem '-ertinib' in the name indicates that Rezivertinib is a epidermal growth factor receptor (EGFR) inhibitor.
Triethylhexanoin
go.drugbank.com/drugs/DB14102InvestigationalTriethylhexanoin is an ingredient of cosmetic products as a fragrant solvent.
Categories: Compounds used in a research, industrial, or household setting